Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1054561

	registered interest
	date	01/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiography: Training
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to tackle reductions in the number of applicants to radiography courses since the end of the NHS bursaries for those courses.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	216167
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The NHS Long Term Plan, published on 7 January 2019, sets out a vital strategic framework to ensure that over the next 10 years the National Health Service will have the staff it needs.</p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care has commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce, including consideration of additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p><p> </p><p>Radiotherapy degree courses are three years in length, therefore students affected by the changes to the education funding system from 2017 will not have completed courses funded by loans to enable an assessment of the effect of the removal of bursaries on this profession.</p><p> </p><p>The Cancer Workforce Plan Phase 1, included a target of upskilling 300 more radiographers in image interpretation and reporting by 2021. Currently, 88 individuals have started training programmes towards this, 62 will start in January, and a further 150 during 2019/20.</p><p> </p><p>Phase 2 of the Cancer Workforce Plan will follow the Workforce Implementation Plan published later in 2019.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 216168 question first answered 07/02/2019 17:28:08 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

1051292

	registered interest
	date	30/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 January 2019 to Question 206215 on Air Pollution, what the implications for his policies are of the statement in the Public Health England report, published in March 2017, entitled Air Quality A Briefing for Directors of Public Health that PM is inhaled into the lungs and ultrafine PM0.1 is thought to pass into the blood causing many adverse outcomes including systemic inflammation.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	214452
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Public Health England (PHE) has developed a programme to support national and local government to reduce the burden of disease attributable to air pollution. This includes awareness raising, developing the evidence base on the health effects of air pollution and interventions aiming to reduce exposure to air pollution and provide wider public health benefits.</p><p> </p><p>PHE undertakes various air quality research projects, working with academic partners, to review the evidence for the health effects of air pollutants. PHE is a partner in two health protection research units (HPRU) funded by the National Institute for Health Research, whose remit includes air pollution research: The Health impact of Environmental Hazards HPRU and the HPRU in Environmental Change and Health. Further information can be found at the following links:</p><p> </p><p><a href="http://hieh.hpru.nihr.ac.uk/" target="_blank">http://hieh.hpru.nihr.ac.uk/</a></p><p> </p><p><a href="http://www.hpru-ech.nihr.ac.uk/" target="_blank">http://www.hpru-ech.nihr.ac.uk/</a></p><p> </p><p>None of the research projects specifically focus on PM0.1 but address air pollution components which are included in this category.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:17:23 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1051336

	registered interest
	date	30/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Autoimmune Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the annual cost to the public purse of treating and managing (a) rheumatoid arthritis, (b) inflammatory bowel disease and (c) psoriasis.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	214623
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>No specific estimate has been made.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:23:09 answering member 4067 label Biography information for Steve Brine
	tabling member	4532 label Biography information for Derek Thomas

1051338

	registered interest
	date	30/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Autoimmune Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether (a) his Department and (b) NHS England have made a comparative assessment of the effectiveness of treating immune-mediated inflammatory conditions (i) holistically and (ii) according to the physical location of the inflammation; and if he will make a statement.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	214625
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>No specific assessment has been made.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:21:20 answering member 4067 label Biography information for Steve Brine
	tabling member	4532 label Biography information for Derek Thomas

1052188

	registered interest
	date	31/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bowel Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Government's announcement of 10 August 2018 that the age for bowel cancer screening in England will be lowered from 60 to 50, what the timetable is for implementing the lower screening age; and what assessment he has made of the effect that staff shortages in endoscopy and pathology services will have on the ability to deliver bowel cancer screening from age 50.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	215179
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Plans are well underway to deliver the commitment in the NHS Long Term Plan to modernise the bowel cancer screening programme; faecal immunochemical testing at 120ug/g will be integrated into the programme from April 2019.</p><p> </p><p>NHS England has committed to, over time, lowering the starting age for bowel screening from 60 currently to 50. This is being discussed by NHS England, the Department and Public Health England, and the final timetable will take into account modelling and feedback received from the system (commissioners, providers and cancer alliances).</p><p> </p><p>For a safe, sustainable and high-quality service extended to age 50 years, there is a requirement to balance workforce requirements for the current commitments and Health Education England has pledged to fund the training of 400 clinical endoscopists by 2021 to significantly increase endoscopy capacity in England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 215180 question first answered 07/02/2019 15:24:54 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

1052189

	registered interest
	date	31/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bowel Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to introduce the faecal immunochemical test for the Bowel Cancer Screening Programme.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	215180
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Plans are well underway to deliver the commitment in the NHS Long Term Plan to modernise the bowel cancer screening programme; faecal immunochemical testing at 120ug/g will be integrated into the programme from April 2019.</p><p> </p><p>NHS England has committed to, over time, lowering the starting age for bowel screening from 60 currently to 50. This is being discussed by NHS England, the Department and Public Health England, and the final timetable will take into account modelling and feedback received from the system (commissioners, providers and cancer alliances).</p><p> </p><p>For a safe, sustainable and high-quality service extended to age 50 years, there is a requirement to balance workforce requirements for the current commitments and Health Education England has pledged to fund the training of 400 clinical endoscopists by 2021 to significantly increase endoscopy capacity in England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 215179 question first answered 07/02/2019 15:24:54 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

1052190

	registered interest
	date	31/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bowel Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department have made of the effect of delays to the introduction of the faecal immunochemical test to the Bowel Cancer Screening Programme on (a) the diagnosis rates of Bowel Cancer at (i) stage one, (ii) stage two, (iii) stage three and (iv) stage four and (b) the mortality rates of bowel cancer in England.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	215181
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>There has been no assessment of the effect of delays to the introduction of faecal immunochemical test to the Bowel Cancer Screening Programme on the diagnosis rates of Bowel Cancer at stage one, stage two, stage three and stage four, or on the mortality rates of bowel cancer in England.</p><p> </p><p>The National Health Service in England already has a world class bowel cancer screening programme for people aged 60-74 years, with survival rates improving year on year. Regular bowel cancer screening has been shown to reduce the risk of dying from bowel cancer by 16%, and around 60% of bowel cancer patients now survive five years or more compared to around 25% 40 years ago. Over 95% of men and women survive for five years or more if their bowel cancer is diagnosed at stage one.</p><p> </p><p>The NHS Long Term Plan includes a proposal to modernise the bowel cancer screening programme to detect more cancers earlier and faecal immunochemical testing at 120ug/g will be integrated into the programme from April 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:19:47 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

1051485

	registered interest
	date	30/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what representations his Department has made to the pharmaceutical company Abbott on the availability of FreeStyle Libre being issued to people with Type 1 diabetes from April 2019.
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	uin	214473
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>On 14 November 2018, it was announced that flash glucose monitors will be available on prescription for every patient who qualifies for them, in line with National Health Service clinical guidelines.</p><p> </p><p>The Department has not made any representations to Abbott since.</p><p> </p><p>Clinical commissioning groups (CCGs) are responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This should include consideration of access to diabetes technologies such as FreeStyle Libre.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:18:43 answering member 4067 label Biography information for Steve Brine
	tabling member	338 label Biography information for Keith Vaz

1052425

	registered interest
	date	01/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatic Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy that pancreatic cancer patients receive treatment within 20 days of diagnosis.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	215608
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The NHS Long Term Plan published in January 2019 sets out the Government’s ambitions to see 55,000 more people surviving cancer for five years in England each year from 2028 and three quarters of all cancers detected at an early stage by 2028. To achieve these targets, we will need to make significant progress on survival across all cancers, including pancreatic cancer.</p><p> </p><p>NHS England will shortly be introducing a Faster Diagnostic Standard of 28 days for all cancer patients which, when taken together with the 62-day referral to treatment standard, will mean that all patients should expect to start their treatment within 34 days of diagnosis. This is a maximum, and trusts should continue to treat patients more quickly particularly where there is a strong clinical need.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:20:39 answering member 4067 label Biography information for Steve Brine
	tabling member	4658 label Biography information for Alex Sobel

1051440

	registered interest
	date	30/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Kawasaki Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps he is taking to raise awareness of the signs and symptoms of Kawasaki disease among NHS health professionals.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	214517
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Guidance is available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p> </p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p><p> </p><p>Information about the symptoms, causes, diagnosis, treatment and complications of Kawasaki disease is also available on the National Health Service website.</p><p> </p><p>Furthermore, learning information and resources for clinicians about Kawasaki disease is available from Societi, The UK Kawasaki Disease Foundation. Societi engages with a range of NHS stakeholders to raise awareness of Kawasaki disease, and has a number of senior clinicians on its Scientific Advisory Board who work in leading NHS institutions and who have expertise in relevant clinical areas such as vasculitis and paediatric cardiology.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:22:23 answering member 4067 label Biography information for Steve Brine
	tabling member	1400 label Biography information for Kevin Brennan